News
Activities by Mirai Medical Group
The University of Tokyo announces that NMN improves motor functions
June 8, 2022
The research group formed by Assistant Professor Masaki Igarashi, Dr. Yoshiko Nakagawa, Dr. Masaomi Miura, and Professor Toshimasa Yamauchi of the Department of Diabetes and Metabolism, University of Tokyo Hospital, administered orally NMN, a precursor of NAD+, in a randomized, placebo-controlled, double-blind experiment to healthy male seniors to study its effects on the aging phenomenon, starting with muscular weakness.
The healthy elderly men took 250 mg of NMN per day for 12 weeks. As a result, their levels of NAD+ and related metabolites in blood increased and motor functions, such as walking or holding objects, improved. Furthermore, it was found that the oral intake of NMN tends to improve hearing.
Click here for details (text in Japanese.)
World's first! NAD measurement at a private medical institution
April 21, 2022
The Tokyo Ginza Wellness & Aging Clinic of Mirai Medical Group has achieved the measurement of nicotinamide adenine dinucleotide (NAD) contained in human peripheral blood mononuclear cells.
This is the first time in the world for a private medical institution to measure NAD, a marker of aging, before and after taking nicotinamide mononucleotide (NMN). This information is useful for daily health management. For example, it can help establish how much NMN should take a certain individual in order to maintain NAD levels.
Click here for the press release (text in Japanese.)
OIST Partner Agreement
April 1, 2022
We are pleased to inform you that Mirai Medical Group/ Tokyo Ginza Wellness & Aging Clinic have signed a partnership contract with Okinawa Institute of Science and Technology Graduate University (OIST).
Click here for INO Members
.png)
Method to obtain anti-aging effects and method to determine aging degree using eNAMPT-EVs
April 1, 2022
Tokyo Ginza Wellness & Aging Clinic has welcomed a researcher from the Institute for Research on Productive Aging (IRPA; Representative Director: Prof. Shin-ichiro Imai) to its laboratory and started a joint research with IRPA on April 1, 2022.
The Tokyo Ginza Wellness & Aging Clinic of Mirai Medical Corporation, where Professor Shinichiro Imai (M. and T. Tanaka Family Distinguished Professor in Aging Research, Washington University School of Medicine, St. Louis, Missouri) serves on the board of directors, are pleased to announce that Medical Support is provided by Mirailab Bioscience, Inc.
・ Institute for Research on Productive Aging
・ Mirai Medical Group
・ Tokyo Ginza Wellness & Aging Clinic
Professor Shin-ichiro Imai, Director of Mirai Medical Group, receives the prestigious title of "M. and T. Tanaka Family Distinguished Professor in Aging Research" at the University of Washington.
December 20, 2021
Mirailab Bioscience, Inc. has been recognized for its significant contributions, including donations to anti-aging research at Washington University in St. Louis (Missouri, USA), and has honored Professor Shin-ichiro Imai, M.D., Ph.D., who has made significant achievements as a professor of Developmental Biology and Medicine at Washington University, with the title of "M and T Tanaka Family Distinguished Professor", that bears the names of our CEO and our Executive Chairman. "Distinguished Professor" is the highest distinction in an American university. This is an unprecedented achievement, as this is the first time in the 170 years of history of the University that such distinction bears the name of a Japanese family.
Click here for the installation ceremony
https://livestream.com/accounts/7945443/events/9991212
Click here for press release (text in Japanese.)
https://www.atpress.ne.jp/news/291749
Picture (Top): Jeffrey I. Gordon M.D.
Bottom from left to right: Dr. Samuel Klein M.D., Dr. Imai and Mrs Imai, and Mrs and Mr Tanaka (CEO and Executive Chairman of Mirailab Bioscience Inc.)c.)
Lecture on the occasion of the opening of Tokyo Ginza Wellness & Aging Clinic
November 6, 2021
Shin-ichiro Imai, Director of the Group, gave a conference entitled "Exploring the Future of Anti-Aging Medicine: Cutting Edge of Research on Aging and Life Span and Its Social Implementation".
